INEDSYS
Menu
Theme
Privacy PolicyTerms of Service
Speakers
Dr. ⁨Channa Jayasekera⁩

Dr. ⁨Channa Jayasekera⁩MD

Transplant Hepatologist

Mayo ClinicArizonaORCID 0000-0003-4579-840X
0
Talks given
0
Publications
0
Followers

About

Transplant Hepatologist at Mayo Clinic Arizona

Areas of focus

Liver Transplant

Publications

Advances in liver transplantation for hepatic malignancies.

Woelfel, Ingrid, Lowmaster, Shirley, Chavez-Villa, Mariana, Arias, Sandra, Jayasekera, Channa, Barnhill, Michele, et al. · Hepatic oncology · 2026PubMed

Correction: Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)?

Sandrasegaran, Kumaresan, Shah, Amar S, Thompson, Cole P, Jayasekera, Channa R, Carey, Elizabeth J, Jain, Ayana, et al. · European radiology · 2026PubMed

Reply to the Letter to the Editor: Gadoxetate-enhanced MRI in sclerosing cholangitis-linking primary and secondary cholangiopathy through functional biliary excretion.

Sandrasegaran, Kumaresan, Shah, Amar S, Thompson, Cole P, Jayasekera, Channa R, Carey, Elizabeth J, Venkatesh, Sudhakar K, et al. · European radiology · 2026PubMed

Overall Outcomes of Liver Transplantation Using Upfront Normothermic Machine Perfusion: A Real-World Single-Center Experience.

Nguyen, Michelle C, Ohara, Stephanie Y, Barnhill, Michele, Madisetty, Alekhya, Zhang, Nan, Wiederkehr, Henrique, et al. · Annals of surgery · 2026PubMed

Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)?

Sandrasegaran, Kumaresan, Shah, Amar S, Thompson, Cole P, Jayasekera, Channa R, Carey, Elizabeth J, Jain, Ayana, et al. · European radiology · 2026PubMed

Preemptive anticraving therapies reduce alcohol relapse after liver transplantation in high-risk individuals.

Jayasekera, Channa R, de Borba Engster, Pedro Henrique, Terwilliger, Emma C, Sinha, Shirshendu, Julie Lankton, Lpc, Nguyen, Michelle C, et al. · Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2026PubMed

Simultaneous Heart-Liver Transplant Using Dual-Organ Normothermic Machine Perfusion Following Donation After Circulatory Death: A Case Report.

Ohara, Stephanie Y, Aslam, Usman, Lemond, Lisa M, Steidley, David E, Sen, Ayan, Jayaraman, Arun L, et al. · Transplantation proceedings · 2026PubMed

Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.

Jamal, Fares, Elshaer, Amani, Odeh, Nour B, Alatout, Mayar H, Shahin, Tala, Worden, Astin R, et al. · Life (Basel, Switzerland) · 2025PubMed

Long-Term Outcomes of Fenofibrate for Treatment of Ischemic Cholangiopathy in Donation After Circulatory Death Liver Transplantation.

Jayasekera, Channa R, Barnhill, Michele, Chascsa, David M H, Croome, Kristopher P, Carey, Elizabeth J, Vargas, Hugo E · Clinical transplantation · 2025PubMed

Transforming Hepatocellular Carcinoma Treatment in Lower Income Countries.

Jayasekera, Channa R, Rajasooriyar, Chrishanthi, Richards, Clayton, Arora, Sanjeev, Borad, Mitesh J · Mayo Clinic proceedings · 2025PubMed

Imaging of Ischemic Cholangiopathy Following Donation after Circulatory Death Liver Transplant.

Zulfiqar, Maria, Sugi, Mark, Venkatesh, Sudhakar K, Loh, Jiezhen Tracy, Ludwig, Daniel R, Ballard, David H, et al. · Radiographics : a review publication of the Radiological Society of North America, Inc · 2024PubMed

Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant.

Liu, Margaret C, Lizaola-Mayo, Blanca, Jayasekera, Channa R, Mathur, Amit K, Katariya, Nitin, Aqel, Bashar, et al. · Journal of gastrointestinal cancer · 2024PubMed

Fenofibrate Improves Outcomes in Ischemic Cholangiopathy After Liver Transplantation.

Jayasekera, Channa R, Barnhill, Michele, Chascsa, David M, Aqel, Bashar, Carey, Elizabeth J, Vargas, Hugo E · Gastroenterology · 2023PubMed

An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma.

Wong, Robert J, Jayasekera, Channa, Jones, Patricia, Kanwal, Fasiha, Singal, Amit G, Ahmed, Aijaz, et al. · Gastroenterology research · 2022PubMed

Targeted Electronic Patient Portal Messaging Increases Hepatitis C Virus Screening in Primary Care: a Randomized Study.

Halket, Douglas, Dang, Jimmy, Phadke, Anuradha, Jayasekera, Channa, Kim, W Ray, Kwo, Paul, et al. · Journal of general internal medicine · 2022PubMed

Solid Organ Transplantation From SARS-CoV-2-infected Donors to Uninfected Recipients: A Single-center Experience.

Jayasekera, Channa R, Vikram, Holenarasipur R, Rifat, Zeeshan, Wagler, Josiah, Okubo, Keita, Braaksma, Brandon R, et al. · Transplantation direct · 2022PubMed

Primary Sclerosing Cholangitis: Epidemiology, Genetics, Diagnosis, and Current Management.

Gochanour, Eric, Jayasekera, Channa, Kowdley, Kris · Clinical liver disease · 2020PubMed

Evolving endoscopy teaching in the era of the millennial trainee.

Soetikno, Roy, Kolb, Jennifer M, Nguyen-Vu, Tiffany, Jayasekera, Channa R, Bogie, Roel, Yu, Jessica, et al. · Gastrointestinal endoscopy · 2019PubMed

The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C.

Yoo, Eric R, Perumpail, Ryan B, Cholankeril, George, Jayasekera, Channa R, Ahmed, Aijaz · Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2017PubMed

Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals.

Yoo, Eric R, Perumpail, Ryan B, Cholankeril, George, Jayasekera, Channa R, Ahmed, Aijaz · Journal of clinical and translational hepatology · 2017PubMed

Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma.

Kutsenko, Alina, Ladenheim, Maya R, Kim, Nathan, Nguyen, Pauline, Chen, Vincent, Jayasekera, Channa, et al. · Journal of clinical gastroenterology · 2017PubMed

Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States.

Jayasekera, Channa R, Beckerman, Rachel, Smith, Nathaniel, Perumpail, Ryan B, Wong, Robert J, Younossi, Zobair M, et al. · Journal of clinical and translational hepatology · 2017PubMed

Task-shifting - A practical strategy to improve the global access to treatment for chronic hepatitis C.

Yoo, Eric R, Perumpail, Ryan B, Cholankeril, George, Jayasekera, Channa R, Ahmed, Aijaz · International journal of nursing studies · 2016PubMed

Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule.

Cholankeril, George, Perumpail, Ryan B, Tulu, Zeynep, Jayasekera, Channa R, Harrison, Stephen A, Hu, Menghan, et al. · Gastroenterology · 2016PubMed

Trends in Liver Transplantation in Hepatitis C Virus-Infected Persons, United States.

Perumpail, Ryan B, Wong, Robert J, Liu, Andy, Jayasekera, Channa R, Dieterich, Douglas T, Younossi, Zobair M, et al. · Emerging infectious diseases · 2016PubMed

Task-Shifting: An Approach to Decentralized Hepatitis C Treatment in Medically Underserved Areas.

Jayasekera, Channa R, Perumpail, Ryan B, Chao, David T, Pham, Edward A, Aggarwal, Avin, Wong, Robert J, et al. · Digestive diseases and sciences · 2015PubMed

Treating hepatitis C in lower-income countries.

Jayasekera, Channa R, Barry, Michele, Roberts, Lewis R, Nguyen, Mindie H · The New England journal of medicine · 2014PubMed

Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1.

Jayasekera, Channa R, Harris, Jason B, Bhuiyan, Saruar, Chowdhury, Fahima, Khan, Ashraful I, Faruque, Abu S G, et al. · The Journal of infectious diseases · 2008PubMed

Nutritional status of children under five in three state foster care institutions in Sri Lanka.

Jayasekera, Channa R · The Ceylon medical journal · 2006PubMed

Connect

ORCID